Multiple Sclerosis
07.14.24
Copy Link
Like
Robert Bermel, MD, Director of the Mellen Center for Multiple Sclerosis, Cleveland Clinic, provides an overview of the 10-year study data demonstrating Ocrevus treatment reduces disability in participants with MS.
Sign up to receive alerts and updates from The Neurology Hub.
Thanks for subscribing
Do you have cases, images, or other information to share? The Neurology Hub welcomes submissions from clinicians and researchers at all levels.
Contribute Here